EMMPRIN Expression Is Required for Response to Bevacizumab Therapy in HNSCC Xenografts
Cancer Letters - Ireland
doi 10.1016/j.canlet.2008.09.033
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2009
Authors
Publisher
Elsevier BV
Available in full text
February 1, 2009
Elsevier BV